Donnerstag, 31. August 2017

Tikituka 99.99% in HIV

Tikituka 99.99% in HIV
In a clinical study with AIDS patients (80 patients received over 6 weeks Tikitua 99.99% (twice daily), 70 patients received placebo.
Of the patients, 67% were evaluable. In 41% of the Tikituka group (and only 4% in the placebo group) an appetite was found. The appetite-stimulating effect can be obtained over a continuous period of time. There were no side effects with antiretroviral substances or other medicines used in the studies. Similar results have been found in further studies. It is interesting to note that increased caloric intake was only observed in patients with a severely reduced weight, but not in HIV patients without signs of emaciation.
A UK study of 2009 found that out of 164 HIV-infected more than half a significant improvement in symptoms nausea, anxiety, nervous pain, depression, tingling, numbness, weight loss, headache, tremors, constipation and debility
By the consumption of Tikituka.

Keine Kommentare:

Kommentar veröffentlichen